0MET.LSE

Konecranes ABP

0MET.LSE, UK

Konecranes Plc manufactures, sells, and services material handling products in Europe, the Middle East, Africa, the Americas, the Asia-Pacific, and internationally. It operates through three segments: Service, Industrial Equipment, and Port Solutions. The Service segment provides specialized maintenance services and spare parts for all types of industrial cranes and hoists. The Industrial Equipment segment offers industrial cranes and wire rope hoists, digital controls, software and automation; chain hoists, workstation lifting systems, overhead cranes, cranes and hoists, low headroom hoist, electric chain hoist, and crane and electric chain hoist for hazardous environments. The Port Solutions segment provides equipment, services and software, and products, such as ship-to shore cranes, rubber-tired gantry cranes, lift trucks, mobile harbor cranes, straddle carriers, automated guided vehicles, and automated stacking cranes. It also offers maintenance and repair services, electrified lift trucks, and spare parts for the container. It serves general manufacturing metals production, power generation, automotive, pulp and paper, raw materials and chemicals, container handling industry, and ports and terminal customers. The company was founded in 1910 and is headquartered in Hyvinkää, Finland.

https://www.konecranes.com

Stock Price

€0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
0MET.LSE
stock
0MET.LSE

Shell (LSE:SHEL): Exploring Its Valuation as Shares Extend Steady 2024 Gains Yahoo Finance

Read more →
0MET.LSE
stock
0MET.LSE

Chester technology business GBG celebrates London Stock Exchange move chesterstandard.co.uk

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2022-12-31)

Health Score

Investors

* Institutions hold a combined 0.00% of the total shares of Konecranes ABP

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

1.51

Latest Release

Date

2025-09-30

EPS Actual

1.3104

EPS Estimate

1.24

EPS Difference

0.0704

Surprise Percent

5.6774%

Investing Fit Scorecard

(Last Updated 2022-12-31)

Deep Value
Weak Deep Value(0.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(1.5)
GARP
Not Attractive for GARP(0)
Growth
Weak Growth Prospect(0)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(0)
Quality
Low Quality Business(0.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2022-12-31)

Revenue

€ 0

Cost Of Revenue

€ 0

Gross Profit

€ 0

Operating Expenses

€ 0

Operating Income

€ 0

Interest Expense

€ 0

Pretax Income

€ 0

Net Income

€ 0

Income Tax Expense

€ 0

EBITDA

€ 0

Total Other Income Expense Net

€ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2022-12-31)

Cash

0

Short Term Investments

0

Receivables

0

Inventories

0

Total Current Assets

0

Property Plant Equipment

0

Total Assets

0

Payables

0

Short Term Debt

0

Long Term Debt

0

Total Liabilities

0

Equity

0

Trend

Cash Flow

(Last Updated 2022-12-31)

Net Income

0

Depreciation

0

Change In Working Capital

0

Cash From Operations

0

Capital Expenditures

0

Cash From Investing

0

Cash From Financing

0

Net Change In Cash

0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.